Sales decline 18.68% to Rs 44.22 crore
Net Loss of Vivimed Labs reported to Rs 22.03 crore in the quarter ended September 2022 as against net loss of Rs 23.30 crore during the previous quarter ended September 2021. Sales declined 18.68% to Rs 44.22 crore in the quarter ended September 2022 as against Rs 54.38 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales44.2254.38 -19 OPM %-21.05-19.25 -PBDT-18.01-18.95 5 PBT-22.03-23.30 5 NP-22.03-23.30 5Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
